ADA and X-linked adrenoleukodystrophy: Gamma retroviral and lentiviral vectors have performed well for ex vivo gene therapy of hematopoietic stem cells for treatment of X-SCID [166], ADA-SCID [167] and X-linked Adrenoleukodystrophy [168].